<VariationArchive VariationID="2972070" VariationName="NM_001395413.1(POR):c.828del (p.Phe276fs)" VariationType="Deletion" Accession="VCV002972070" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3139785" VariationID="2972070">
      <GeneList>
        <Gene Symbol="LOC126860075" FullName="CDK7 strongly-dependent group 2 enhancer GRCh37_chr7:75612087-75613286" GeneID="126860075" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="75982769" stop="75983968" display_start="75982769" display_stop="75983968" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="POR" FullName="cytochrome p450 oxidoreductase" GeneID="5447" HGNC_ID="HGNC:9208" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="75915155" stop="75986855" display_start="75915155" display_stop="75986855" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="75544419" stop="75616172" display_start="75544419" display_stop="75616172" Strand="+" />
          </Location>
          <OMIM>124015</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001395413.1(POR):c.828del (p.Phe276fs)</Name>
      <CanonicalSPDI>NC_000007.14:75983523:TTT:TT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="75983524" stop="75983524" display_start="75983524" display_stop="75983524" variantLength="1" positionVCF="75983523" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="75612842" stop="75612842" display_start="75612842" display_stop="75612842" variantLength="1" positionVCF="75612841" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>F276fs</ProteinChange>
      <ProteinChange>F294fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.75612844del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.75612844del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.75983526del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.75983526del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008930.1" sequenceAccession="NG_008930" sequenceVersion="1" change="g.73425del">
            <Expression>NG_008930.1:g.73425del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_084576.1" sequenceAccession="NG_084576" sequenceVersion="1" change="g.858del">
            <Expression>NG_084576.1:g.858del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000941.2" sequenceAccession="NM_000941" sequenceVersion="2" change="c.837delT">
            <Expression>NM_000941.2:c.837delT</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000932.3" sequenceAccession="NP_000932" sequenceVersion="3" change="p.Phe279Leufs">
            <Expression>NP_000932.3:p.Phe279Leufs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000941.3" sequenceAccession="NM_000941" sequenceVersion="3" change="c.837delT">
            <Expression>NM_000941.3:c.837delT</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000932.3" sequenceAccession="NP_000932" sequenceVersion="3" change="p.Phe279Leufs">
            <Expression>NP_000932.3:p.Phe279Leufs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001367562.3" sequenceAccession="NM_001367562" sequenceVersion="3" change="c.828del">
            <Expression>NM_001367562.3:c.828del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001354491.2" sequenceAccession="NP_001354491" sequenceVersion="2" change="p.Phe276fs">
            <Expression>NP_001354491.2:p.Phe276fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001382655.3" sequenceAccession="NM_001382655" sequenceVersion="3" change="c.882del">
            <Expression>NM_001382655.3:c.882del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001369584.2" sequenceAccession="NP_001369584" sequenceVersion="2" change="p.Phe294fs">
            <Expression>NP_001369584.2:p.Phe294fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001382657.2" sequenceAccession="NM_001382657" sequenceVersion="2" change="c.828del">
            <Expression>NM_001382657.2:c.828del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001369586.2" sequenceAccession="NP_001369586" sequenceVersion="2" change="p.Phe276fs">
            <Expression>NP_001369586.2:p.Phe276fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001382658.3" sequenceAccession="NM_001382658" sequenceVersion="3" change="c.828del">
            <Expression>NM_001382658.3:c.828del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001369587.2" sequenceAccession="NP_001369587" sequenceVersion="2" change="p.Phe276fs">
            <Expression>NP_001369587.2:p.Phe276fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001382659.3" sequenceAccession="NM_001382659" sequenceVersion="3" change="c.828del">
            <Expression>NM_001382659.3:c.828del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001369588.2" sequenceAccession="NP_001369588" sequenceVersion="2" change="p.Phe276fs">
            <Expression>NP_001369588.2:p.Phe276fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001382662.3" sequenceAccession="NM_001382662" sequenceVersion="3" change="c.828del">
            <Expression>NM_001382662.3:c.828del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001369591.2" sequenceAccession="NP_001369591" sequenceVersion="2" change="p.Phe276fs">
            <Expression>NP_001369591.2:p.Phe276fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001395413.1" sequenceAccession="NM_001395413" sequenceVersion="1" change="c.828del" MANESelect="true">
            <Expression>NM_001395413.1:c.828del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001382342.1" sequenceAccession="NP_001382342" sequenceVersion="1" change="p.Phe276fs">
            <Expression>NP_001382342.1:p.Phe276fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001395413.1(POR):c.828del (p.Phe276fs) AND Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency" Accession="RCV003835196" Version="1">
        <ClassifiedConditionList TraitSetID="5548">
          <ClassifiedCondition DB="MedGen" ID="C1860042">Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-03-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14758361</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20732302</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21741353</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5548" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="12699" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">DISORDERED STEROIDOGENESIS DUE TO POR DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="613571" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency</ElementValue>
                <XRef ID="MONDO:0013310" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency</ElementValue>
                <XRef ID="Disordered+steroidogenesis+due+to+cytochrome+p450+oxidoreductase+deficiency/8271" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ABS1</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cytochrome P450 oxidoreductase deficiency (PORD) is a disorder of steroidogenesis with a broad phenotypic spectrum including cortisol deficiency, altered sex steroid synthesis, disorders of sex development (DSD), and skeletal malformations of the Antley-Bixler syndrome (ABS) phenotype. Cortisol deficiency is usually partial, with some baseline cortisol production but failure to mount an adequate cortisol response in stress. Mild mineralocorticoid excess can be present and causes arterial hypertension, usually presenting in young adulthood. Manifestations of altered sex steroid synthesis include ambiguous genitalia/DSD in both males and females, large ovarian cysts in females, poor masculinization and delayed puberty in males, and maternal virilization during pregnancy with an affected fetus. Skeletal malformations can manifest as craniosynostosis, mid-face retrusion with proptosis and choanal stenosis or atresia, low-set dysplastic ears with stenotic external auditory canals, hydrocephalus, radiohumeral synostosis, neonatal fractures, congenital bowing of the long bones, joint contractures, arachnodactyly, and clubfeet; other anomalies observed include urinary tract anomalies (renal pelvic dilatation, vesicoureteral reflux). Cognitive impairment is of minor concern and likely associated with the severity of malformations; studies of developmental outcomes are lacking.</Attribute>
                <XRef ID="NBK1419" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12664" />
                <XRef ID="12664" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301592</ID>
                <ID Source="BookShelf">NBK1419</ID>
              </Citation>
              <XRef ID="95699" DB="Orphanet" />
              <XRef ID="C1860042" DB="MedGen" />
              <XRef ID="MONDO:0013310" DB="MONDO" />
              <XRef Type="MIM" ID="613571" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8586134" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="12653775|MedGen:C2673964" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004630879" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14758361</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20732302</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21741353</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with POR-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Phe279Leufs*17) in the POR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POR are known to be pathogenic (PMID: 14758361, 20732302, 21741353).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.75612842del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2673964" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8586134" TraitType="Disease" MappingType="XRef" MappingValue="C2673964" MappingRef="MedGen">
        <MedGen CUI="C1860042" Name="Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

